| Detected | Trial | Change |
|---|---|---|
| 2026-06-10 | NCT07490301 A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With… |
Recruitment opened |
| 2026-06-10 | NCT07490301 A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With… |
Trial sites expanded: 0 -> 9 locations |
| 2026-06-06 | NCT05125302 Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the… |
Trial sites expanded: 124 -> 129 locations |
| 2026-06-05 | NCT06849791 A Study to Assess the Relative Bioavailability of Oral ABBV-932 in Healthy Adult… |
Trial completed |
| 2026-06-05 | NCT06849791 A Study to Assess the Relative Bioavailability of Oral ABBV-932 in Healthy Adult… |
date change Primary completion pushed: 2026-03 -> 2026-05-08 |
| 2026-06-05 | NCT06849791 A Study to Assess the Relative Bioavailability of Oral ABBV-932 in Healthy Adult… |
date change Completion pushed: 2026-03 -> 2026-05-08 |
| 2026-06-05 | NCT04189614 An Efficacy and Safety Study of Cofetuzumab Pelidotin in Participants With… |
Trial terminated |
| 2026-06-05 | NCT04189614 An Efficacy and Safety Study of Cofetuzumab Pelidotin in Participants With… |
critical why stopped: null → "Strategic considerations" |
| 2026-06-05 | NCT07566130 A Study to Assess Adverse Events, Tolerability and How Single and Ascending Oral Doses of… |
Trial completed |
| 2026-06-03 | NCT05445778 Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in… |
date change Primary completion moved earlier: 2032-05 -> 2027-04 |
| 2026-06-03 | NCT06568939 A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin… |
Trial sites expanded: 64 -> 71 locations |
| 2026-06-03 | NCT05753501 Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves… |
Trial arms changed: 3 -> 4 |
| 2026-06-03 | NCT07306832 A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves… |
Recruitment opened |
| 2026-06-03 | NCT07306832 A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves… |
Trial sites expanded: 0 -> 5 locations |
| 2026-06-03 | NCT07306832 A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves… |
date change Completion pushed: 2028-04 -> 2030-03 |
| 2026-06-03 | NCT06953960 A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone… |
Enrollment increased: 130 -> 199 participants |
| 2026-06-03 | NCT06953960 A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone… |
Trial sites expanded: 32 -> 46 locations |
| 2026-06-03 | NCT06772623 Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab… |
Trial sites expanded: 92 -> 96 locations |
| 2026-06-02 | NCT06575192 Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast… |
Primary endpoint(s) modified |
| 2026-06-02 | NCT06575192 Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast… |
Enrollment reduced: 783 -> 264 participants |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-05-27 | NCT07607964 A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness… | Phase 1 | Recruiting |
| 2026-05-22 | NCT07600762 A Study to Assess Adverse Events, Tolerability and How a Single Oral Dose of Nacresertib… | Phase 1 | Not Yet Recruiting |
| 2026-05-22 | NCT07604545 A Study to Assess the Use of Artificial Intellignce to Predict Eye Treatment Changes in… | Not Yet Recruiting | |
| 2026-05-22 | NCT07604558 A Study to Assess the Adverse Events and How Bretisilocin Intramuscular Injection Moves… | Phase 1 | Not Yet Recruiting |
| 2026-05-20 | NCT07599670 A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenous… | Phase 1/2 | Not Yet Recruiting |
| 2026-05-20 | NCT07599761 A Phase 1 Study to Assess the Effect of Itraconazole on ABBV-722 in Healthy Adult… | Phase 1 | Recruiting |
| 2026-05-18 | NCT07592273 Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With… | Phase 2/3 | Recruiting |
| 2026-05-14 | NCT07587008 Study to Assess Adverse Events and How Oral Emraclidine Moves Through the Body of Adult… | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07044687 | Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in… | Acute Myeloid Leukemia | Recruiting |
| NCT07122583 | A Study to Assess Non-Invasive Subcutaneous Fat Reduction in the Submental, Inner Thigh… | Non-Surgical Fat Reduction | Active, Not Recruiting |
| NCT07186595 | A Study to Evaluate the Safety and Effectiveness of JUVÉDERM Products in Adult… | Mid Face Volume Deficit | Active, Not Recruiting |
| NCT05821855 | A Study to Evaluate Adverse Events and Change in Disease Activity With the XEN45 Glaucoma… | Open-angle Glaucoma | Active, Not Recruiting |
| Phase 3 | |||
| NCT05889182 | A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in… | Hidradenitis Suppurativa | Recruiting |
| NCT07284381 | A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear… | Dry Eye Disease | Recruiting |
| NCT06461897 | A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral… | Atopic Dermatitis | Recruiting |
| NCT06428019 | A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants… | Chronic Lymphocytic Leukemia | Recruiting |
| NCT05407636 | Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD | AMD | Recruiting |
| NCT06012240 | A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and… | Alopecia Areata | Recruiting |
| NCT05711394 | A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant… | Episodic Migraine | Recruiting |
| NCT06100744 | A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves… | Juvenile Psoriatic Arthritis | Recruiting |
| NCT06389136 | A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis… | Atopic Dermatitis | Recruiting |
| NCT05609630 | Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in… | Juvenile Idiopathic Arthritis | Recruiting |
| NCT07007065 | Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and… | Neovascular Age-related Macular Degeneration | Recruiting |
| NCT05995353 | A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and… | Crohn's Disease | Recruiting |
| NCT06575192 | Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast… | Breast Reconstruction | Recruiting |
| NCT06822738 | A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation… | Primary Open Angle Glaucoma | Recruiting |
| NCT06417775 | Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult… | Migraine | Recruiting |
| NCT04777357 | A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in… | Depression | Recruiting |
| NCT06332534 | Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric… | Crohn's Disease | Recruiting |
| NCT06734351 | A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult… | Mid Face Volume Deficit | Recruiting |
| NCT06810505 | A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity… | Chronic Migraine | Recruiting |
| NCT07071519 | A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative… | Ulcerative Colitis | Recruiting |
| NCT05125302 | Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the… | Migraine | Recruiting |